Strategic focus Lee Medical’s core service is vascular access insertion and follow-up care across acute, post-acute, outpatient, and home settings, with a focus on infection prevention and cost reduction through concurrent surveillance via their proprietary VAST software. This presents a sales opportunity to healthcare systems seeking standardized, per-procedure vascular access services that align with infection control and value-based care initiatives.

Scale readiness Currently serving over 80 facilities across Tennessee, Kentucky, and Mississippi, Lee Medical demonstrates regional adoption and capacity to partner with hospital networks and post-acute providers. Targeted expansion conversations could focus on multi-facility contracts, workforce scheduling efficiencies, and scalable coverage models for broader geographies.

Tech-enabled Utilizes iPads and proprietary VAST software for real-time device surveillance and quality assurance, signaling an opportunity to position Lee Medical as a technology-enabled partner that helps facilities monitor device-related infections, track outcomes, and potentially integrate with existing EHR workflows.

Performance-based pricing The pricing model charges only for successful insertions with capped charges for scheduled care, which can translate into cost predictability for clients and alignment with value-based purchasing. This can be leveraged to approach cost-conscious buyers and RFPs that emphasize per-procedure efficiency and infection-related cost savings.

Partnership potential With a small-to-mid sized team (11-50 employees) delivering high-skill vascular procedures and collaboration with infection prevention and quality assurance personnel, there is room to form strategic alliances or bundled service agreements with hospital systems, health networks, and regional post-acute providers seeking centralized vascular access expertise and standardized infection surveillance.